← Leaderboards
Kara S Keedy
Aimmax Therapeutics, Inc.
$1,226,801
Attributed
$1,226,801
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $613.4K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
NIH$1,226,801 · 2
By mechanism
R43$1,226,801 · 2
Top collaborators
No co-investigators on record.
Most similar at Aimmax Therapeutics, Inc.
Same institution · by research overlap
- Laurene Wang$3,663,308
Others in their field
Other Rising Stars on “Morbidity - Disease Rate”
- Mary D Shaw · Jackson State University$2,503,974
- Dr Beryl Polk · Jackson State University$2,503,974
- Jun-Chau Chien · University Of California Berkeley$2,328,157
- Deanna Gagne · Gallaudet University$2,061,545
- Rebecca Yates Coley · Kaiser Foundation Research Institute$1,561,963
- Emily Man · Venova Technologies, Inc.$1,508,594
Research focus
Morbidity - Disease RateTissuesInfectionPlasmaResistanceSmall Business Innovation Research GrantDoseEvaluationMouse ModelMulti-Drug ResistancePrevalencePropertyResistance DevelopmentSafetyAntibiotic ResistanceCombatDrug ResistanceEnsureIn VitroIn VivoMortalityMicrobiologyMarketingArginine
Grant awards (4)
Development of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections$306,953
R43 · FY2024 · AI · contact PI
Development of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections$306,954
R43 · FY2023 · AI · contact PI
Optimization and Characterization of Novel Antifungal Peptides$306,408
R43 · FY2023 · AI · contact PI
Optimization and Characterization of Novel Antifungal Peptides$306,486
R43 · FY2022 · AI · contact PI